+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prothrombin Complex Concentrates Market, by Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 149 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5456014
Prothrombin complex concentrates (PCCs) are highly purified concentrate prepared from blood plasma with hemostatic activity contain four vitamin K-dependent clotting factors (F) (II (prothrombin), VII, IX and X), for replacement therapy in patients with congenital or acquired deficiencies.



Moreover, in several European countries, prothrombin complex concentrates are also used in the management of massive peri- and postoperative bleeding.

Market Dynamics


Global Prothrombin Complex Concentrates Market is expected to show significant growth, owing to increasing approval of product. For instance, in 2013, the U.S Food and Drug Administration (FDA) accepted Octapharma USA’s Biological License Application (BLA) for octaplex 4-Factor PCC, for indication of reversal of anticoagulation therapy in patients undergoing vitamin K antagonist therapy with the need for urgent surgery or invasive procedures

Key features of the study:

  • This report provides in-depth analysis of the global prothrombin complex concentrates market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prothrombin complex concentrates market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Octapharma AG, Nihon Pharmaceutical Co Ltd, Grifols S.A., CSL Behring GmbH, Kedrion Biopharma Inc., Shire Plc, China Biologic Products Holdings, Inc., and Sanquin
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prothrombin complex concentrates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prothrombin complex concentrates market

Detailed Segmentation:


Global Prothrombin Complex Concentrates Market, By Type:

  • 3-Factor PCC
  • 4-Factor PCC

Global Prothrombin Complex Concentrates Market, By Application:

  • Acquired Coagulation Factor Deficiency
  • Congenital Coagulation Factor Deficiency
  • Others

Global Prothrombin Complex Concentrates Market, By End User:

  • Hospital
  • Ambulatory Surgical Centres
  • Others

Global Prothrombin Complex Concentrates Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Octapharma AG*
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Nihon Pharmaceutical Co Ltd
  • Grifols S.A.
  • CSL Behring GmbH
  • Kedrion Biopharma Inc.
  • Shire Plc
  • China Biologic Products Holdings, Inc.
  • Sanquin
Frequently Asked Questions about the Prothrombin Complex Concentrates Market

What is the estimated value of the Prothrombin Complex Concentrates Market?

The Prothrombin Complex Concentrates Market was estimated to be valued at $771.2 Million in 2021.

What is the growth rate of the Prothrombin Complex Concentrates Market?

The growth rate of the Prothrombin Complex Concentrates Market is 10.2%, with an estimated value of $1522.3 Million by 2028.

What is the forecasted size of the Prothrombin Complex Concentrates Market?

The Prothrombin Complex Concentrates Market is estimated to be worth $1522.3 Million by 2028.

Who are the key companies in the Prothrombin Complex Concentrates Market?

Key companies in the Prothrombin Complex Concentrates Market include Octapharma AG, Nihon Pharmaceutical Co Ltd, Grifols S.A., CSL Behring GmbH, Kedrion Biopharma Inc., Shire Plc and Sanquin.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Epidemiology
  • Mergers and Acquisitions
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Pipeline Analysis
  • Research and development

4. Global Prothrombin Complex Concentrates Market - Impact of Coronavirus (Covid-19) Pandemic
  • COVID-19 Epidemiology
  • Supply and Demand Analysis

5. Global Prothrombin Complex Concentrates Market, By Type, 2021 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • 3-Factor PCC
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • 4-Factor PCC
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)

6. Global Prothrombin Complex Concentrates Market, By Application, 2021 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Acquired Coagulation Factor Deficiency
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Congenital Coagulation Factor Deficiency
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)

7. Global Prothrombin Complex Concentrates Market, By End User, 2021 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Ambulatory Surgical Centres
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)

8. Global Prothrombin Complex Concentrates Market, By Region, 2021 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2028
  • North America
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Type, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2021 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape
  • Competitive Snapshot
  • Octapharma AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Nihon Pharmaceutical Co Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Grifols S.A.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • CSL Behring GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Kedrion Biopharma Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Shire Plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • China Biologic Products Holdings, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sanquin
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

10. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Octapharma AG
  • Nihon Pharmaceutical Co Ltd
  • Grifols S.A.
  • CSL Behring GmbH
  • Kedrion Biopharma Inc.
  • Shire Plc
  • China Biologic Products Holdings Inc.
  • Sanquin